This article is meant to be a brief commentary on how we, at mjn-neuro, have spent so many days working from home because of the emergency caused by CoVid-19, trying to make it affect us as little as possible.

Since last Thursday 12th March, and following the official recommendations, we have implemented teleworking for mjn-neuro members. This way, the members of our team are carrying out our work normally. Every day at 9:30 we try to have a video call that simulates coffee time in our office. We explain to each other how we and our families are doing, the state of confinement, what tasks we have ahead of us or how we plan the rest of the days we will be at home. Once a week we try to meet (also from distance, of course) in a more relaxed way. In the end, humane treatment is very important these days!

Luckily, mjn-neuro has not been affected in such an important way as other companies and sectors, we can carry out our tasks with some normality.

We have a lot of work ahead of us to meet our goal of being able to help people with epilepsy thanks to our technological solution. And these days we continue to move forward with the idea of meeting our goals during this 2020.

These days we continue to move forward with the idea of meeting our goals during this 2020

Also, these days we have been thinking of how our expertise in the field of artificial intelligence could be used to improve the screening of CoVid-19 patients within the healthcare system. We wanted to try to contribute to help in the current situation.

We would like to emphasize that mjn-neuro is perfectly aligned with the objective of developing digital health solutions that improve the efficiency of health systems. In our case, we can also reduce admissions to emergency services by avoiding the accidents that cause unplanned epileptic seizures. We believe that this objective, in the current circumstances, shows, even more, its importance.

And of course, we wish you all good health and that shortly “normality” will turn to be the most important news.

A cordial greeting to all of you.

The mjn-neuro team.

Leave a Reply

Open chat
Contact with us now
Chat with Anna
¡Hola! 👋🏻
Soy Anna, ¿en qué puedo ayudarte?

The user who fills in the information requested in this form declares to be entitled to do so and is solely responsible for the accuracy and completeness of the data and information entered, expressly exonerating MJN NEUROSERVEIS of any liability that may arise for this entity on the occasion of the information provided through this form.

Yes, I accept

L’usuari que complimenta la informació requerida al present formulari declara estar legitimat per això i es fa responsable exclusiu de la veracitat i integritat de les dades i informació que introdueix, exonerant expressament a MJN NEUROSERVEIS de qualsevol responsabilitat que es pugi generar per aquesta entitat amb ocasió de la informació facilitat a través del present formulari.

Si, accepto

El usuario que cumplimenta la información requerida en el presente formulario declara estar legitimado para ello y se hace responsable exclusivo de la veracidad e integridad de los datos e información que introduce, exonerando expresamente a MJN NEUROSERVEIS de cualquier responsabilidad que pudiera generarse para esta entidad con ocasión de la información facilitada a través del presente formulario.

Sí, acepto

Save the date

The next Saturday 21st of November at 4 pm, you will be able to know first hand our product: mjn-SERAS.
mjn-SERAS is a healthcare product that sends a warning signal when the risk of epileptic seizures is high, to the affected person and their trusted contacts.

Sign up now!

    mjn-SERAS is a medical device with CE marking according to the European Directive 93/42/EEC and the Royal Decree RD. 1591/2009.
    Contraindications: Do not use the product if you suffer from an infection in the ear canal or if you suffer from a skin lesion in the vicinity of the product's area of influence.
    Considerations: This medical product works with an APP only on Android phones. The results tested are 96% sensitivity and 94% specificity.

    Save the date

    El próximo sábado 21 de noviembre a las 4 de la tarde, podrás conocer de primera mano nuestro producto: mjn-SERAS.
    mjn-SERAS es un producto sanitario que lanza una señal de aviso cuando el riesgo de crisis de epilepsia es elevado, a la persona afectada y a sus contactos de confianza.


      mjn-SERAS es un producto sanitario con marcado CE conforme a la Directiva Europea 93/42/EEC y el Real Decreto RD. 1591/2009.
      Contraindicaciones: No usar el producto en caso de padecer una infección en el canal auditivo o en caso de padecer una lesión cutánea en las proximidades del área de influencia del producto.
      Consideraciones: Este producto sanitario funciona con una APP solo en teléfonos Android. Los resultados testeados son 96% de sensibilidad y 94% de especificidad.